Congresul Național al Federației Societăților Române de Cancer

5 Octombrie

---

11:30 – 12:30 > BRCA mutation specific biomarker for targeted therapy in ovarian cancer

• Moderator Conf Dr Dana Lucia Stanculeanu
• Speaker: Prof Dr Tudor Ciuleanu, Dr Dragos Median

12:30 – 13:00 > Contemporary Treatment Strategies in aRCC .Considerations for Patient Management

• Speaker : Prof. Cezary Szczylik (Poland) Prof. Ciuleanu Tudor Eliade

13:00 – 13:30 > Actual challenges in individualizing the treatment for mCRPC patients

• Lector: conf. dr. Gabriel Kacso

13:30 – 14:30 > Lunch 15:30 – 16:30 > A new standard in the treatment of advanced gastric cancer?

• Speakers: Prof dr Tudor Ciuleanu, Conf Dr Laura Mazilu, Dr. Filip Dumitru

16:30 – 17:00 > Centrul Oncologic Sanador. Excelenta in oncologie medicala, radioterapie si medicina nucleara

• Speaker : Dr. Mircea Dediu

17:00 - 17:30 > Coffe break 17:30 – 18:30 > The Art of Innovation makes all the difference

• Moderator: Doctor Mircea Dediu
• Speakeri: Doctor Daniela Grecea, Doctor Larisa Ciule, Doctor Mihai Marinca

---

6 OCTOMBRIE

---

11:00 – 11:30 - Soft tissue sarcoma - a real chanllenge!

• Speakers: Dr. Razvan Ovidiu Curca, Conf. Dr. Lucian Stanculeanu

11:30 – 12:00 New therapeutic paradigm in advanced NSCLC and RCC treatment

• Speakers: Prof. Dr. Tudor Ciuleanu

12:30 – 13:00 - The potential of CDK4/6 inhibition

• Speaker : Conf. Dr. Dana Stanculeanu

13:00 – 14:00 – Lunch 14:00 – 14:30 - From Clinical Trials to Clinical Practice. Implementing new paradigms in stage III NSCLC.

• Speaker : Dr Razvan Curca si Dr Laura Mazilu

14:30 – 15:00 - Role of Vectibix in achieving early tumor shrinkage in mCRC

• Speaker : Dediu Mircea, MD

15:00 – 15:30 - Pembrolizumab as first line option in NSCLC with high PD-L1 expression

• Speaker : Dr. Mircea Dediu

15:30 – 16:00 – Coffee break 16:00 – 16:30 - Redefining therapeutic algorithm in metastatic melanoma

• Speaker : Dr. Larisa Ciule

16:30 – 17:00 - An extra chance for patients with prostate cancer resistant to metastatic castration: Jevtana (Cabazitaxel)

• Speaker : Prof. Dr. Tudor Ciuleanu

17:00 – 17:30 - TALKS on mCRC clinical practice

• Speaker : Dr Razvan Curca, Conf Dr Serban Negru

17:30 – 18:00 - Atezolizumab NSCLC Use of Immunotherapy in NSCLC: Success& Challenges in clinical practice Atezolizumab mUC Immunotherapy: advances in mUC management

• Speaker : Dr Mircea Dediu , Conf dr Laura Mazilu

---

14:30 – 17:00 – Sustinere lucrari

---

• Transformari fundamentale in metabolismul cancerului

Autor : Dr. Maria Iuliana Gruia Analiza proteomică a markerilor moleculari plasmatici ca predictori ai cancerului tiroidian diferențiat Autor : Dr. Ancuţa Elena BACIU

• Brahiterapia cu rată ridicată de doza (BT-HDR) în iradierea sarcomului Kapoși (SK)

Autor : Mădălina CROITORIU, Dr. Ancuța Elena BACIU, Drd. Lucia Elena ENCIU, Dr. Gabriel BARANGĂ, Laurențiu BUSUIOC, Miu Cosmin, Conf. Dr. Xenia Elena BACINSCHI

• Efectele biologice induse de 68Ga - conjugat cu peptide asupra celulelor tumorale experimentale

Autor : Marieta Elena Panait, Antonela Busca, Valentiuna Negoita, Mirela Dumitru, Maria Iuliana Gruia

• BIOLOGICAL EFFECTS OF RUTHENIUM (III) COMPOUNDS ASSOCIATED TO CYCLODEXTRINS IN HUMAN COLORECTAL CANCER

Autor : Mirela Mihaila, Camelia Hotnog, Viviana Roman, Marinela Bostan, Valentina Uivarosi, Lorelei I. Brasoveanu

• TREATMENT MODULATION OF BIOMARKERS ASSOCIATED TO COLON CANCER CELL LINES WITH DIFFERENT P53 MUTATIONAL STATUS

Autor: Camelia Mia Hotnog, Mirela Mihaila, Marinela Bostan, Lorelei Irina Brasoveanu

---

17:00 – 17:30 – Coffee break

---

– Coffee break

---

17:30 – 19:00 – Sustinere lucrari

---

• The expression pattern of HOXA11 AS in cervical cancer precursor lesions

Autor : Iulia V. Iancu, Adrian Albulescu, Alina Fudulu, Adriana Plesa, Irina Huica, Demetra Socolov, Gabriela Anton, Anca Botezatu

• Rarity of rare tumors

Autor : Bondei Irina-Mihaela, Todor Nicolae, Nagy Viorica

• Molecular and cellular heterogeneity in glioblastoma: Which are the implications of patient’s care and treatment selection?

Autor: Ionela Bîzu

• Volumetric Modulated Arc Therapy for Total Marrow Irradiation TMI Experience of Bucharest Amethyst Clinic

Autor : Violeta Ciocâltei, Răducu Popa, Daniela Adam, Nicoleta Guraliuc, Florin Ciubotaru

• Experimental validation of CT density table for dose calculation in radiation treatment planning system

Autor : Schultes Noemi, Dordai Dan, Eva Andrea, Farcasanu Alexandru, Domokos Reka

• Butterfly technique for Intensity-modulated radiation therapy (IMRT) and Volumetric-modulated arc therapy (VMAT) in Hodgkin’s lymphoma: A dosimetric comparison

Autor: Farcasanu Alexandru Stefan; Schultes Noemi; Eva Andrea; Dordai Dan; Zahu Renata; Kacso Gabriel

---

14:30 – 17:00 – Sustinere lucrari

---

• Transformari fundamentale in metabolismul cancerului

Autor : Dr. Maria Iuliana Gruia Analiza proteomică a markerilor moleculari plasmatici ca predictori ai cancerului tiroidian diferențiat Autor : Dr. Ancuţa Elena BACIU

• Brahiterapia cu rată ridicată de doza (BT-HDR) în iradierea sarcomului Kapoși (SK)

Autor : Mădălina CROITORIU, Dr. Ancuța Elena BACIU, Drd. Lucia Elena ENCIU, Dr. Gabriel BARANGĂ, Laurențiu BUSUIOC, Miu Cosmin, Conf. Dr. Xenia Elena BACINSCHI

• Efectele biologice induse de 68Ga - conjugat cu peptide asupra celulelor tumorale experimentale

Autor : Marieta Elena Panait, Antonela Busca, Valentiuna Negoita, Mirela Dumitru, Maria Iuliana Gruia

• BIOLOGICAL EFFECTS OF RUTHENIUM (III) COMPOUNDS ASSOCIATED TO CYCLODEXTRINS IN HUMAN COLORECTAL CANCER

Autor : Mirela Mihaila, Camelia Hotnog, Viviana Roman, Marinela Bostan, Valentina Uivarosi, Lorelei I. Brasoveanu

• TREATMENT MODULATION OF BIOMARKERS ASSOCIATED TO COLON CANCER CELL LINES WITH DIFFERENT P53 MUTATIONAL STATUS

Autor: Camelia Mia Hotnog, Mirela Mihaila, Marinela Bostan, Lorelei Irina Brasoveanu

---

17:00 – 17:30 – Coffee break

---

– Coffee break

---

17:30 – 19:00 – Sustinere lucrari

---

• The expression pattern of HOXA11 AS in cervical cancer precursor lesions

Autor : Iulia V. Iancu, Adrian Albulescu, Alina Fudulu, Adriana Plesa, Irina Huica, Demetra Socolov, Gabriela Anton, Anca Botezatu

• Rarity of rare tumors

Autor : Bondei Irina-Mihaela, Todor Nicolae, Nagy Viorica

• Molecular and cellular heterogeneity in glioblastoma: Which are the implications of patient’s care and treatment selection?

Autor: Ionela Bîzu

• Volumetric Modulated Arc Therapy for Total Marrow Irradiation TMI Experience of Bucharest Amethyst Clinic

Autor : Violeta Ciocâltei, Răducu Popa, Daniela Adam, Nicoleta Guraliuc, Florin Ciubotaru

• Experimental validation of CT density table for dose calculation in radiation treatment planning system

Autor : Schultes Noemi, Dordai Dan, Eva Andrea, Farcasanu Alexandru, Domokos Reka

• Butterfly technique for Intensity-modulated radiation therapy (IMRT) and Volumetric-modulated arc therapy (VMAT) in Hodgkin’s lymphoma: A dosimetric comparison

Autor: Farcasanu Alexandru Stefan; Schultes Noemi; Eva Andrea; Dordai Dan; Zahu Renata; Kacso Gabriel

---